Radiopharm Theranostics Limited - Sponsored ADR RADX
1.65
0.08
5.10%
as of 25 Sep
- Market cap
- $24.7M
- P/E
- —
Follow RADX
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
1.16 | 3.01 | 2.67 | 3.37 |
+1 more quarter Free account |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | — | — | — | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
— | — | 0.00 | 0.00 | |
Intangible Assets out of Total Assets |
0.63 | 0.49 | 0.54 | 0.52 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(35.82) | (14.88) | (23.73) | (14.47) | |
Working Capital |
2.06 | 20.18 | 16.14 | 20.33 | |
Capital Expenditures |
— | — | 0.00 | 1.95 | |
Net Current Asset Value |
(10.78) | 3.16 | (2.43) | 2.54 | |
| Other line items | |||||
Quick Ratio |
1.14 | 3.00 | 2.65 | 3.25 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
— | — | 0.00 | 0.00 | |
Average Receivables |
6.25 | — | — | — | |
Average Payables |
7.13 | — | — | — | |
Average Assets |
44.03 | — | — | — | |
Average Common Equity |
16.54 | — | — | — | |
Capex to Sales |
— | — | 0.00 | 0.00 |
Columns are period end dates